Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Catherine M. Engelbert currently holds 4,673.99 shares of Royalty Pharma plc (RPRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Catherine M. Engelbert has been a net buyer of RPRX stock. They have purchased $447.0K and sold $0 worth of shares.
Catherine M. Engelbert's most recent insider trade was on Dec 31, 2025, when they sold 670.75 shares at $305.63 per share.
Catherine M. Engelbert serves as Executive at Royalty Pharma plc (RPRX). They have executed 11 insider transactions totaling $447.0K over their tenure at the company.
Catherine M. Engelbert holds the position of Executive at Royalty Pharma plc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Catherine M. Engelbert has shown a buying trading pattern, with $447.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Catherine M. Engelbert was on Feb 28, 2022, when they purchased $244.2K worth of MCD shares. This transaction involved 1,000 shares at $244.18 per share.
Catherine M. Engelbert currently owns 4,673.99 shares of Royalty Pharma plc (RPRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Catherine M. Engelbert's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Catherine M. Engelbert has 11 Form 4 filings on record as an insider at Royalty Pharma plc.
Set alerts for Catherine M. Engelbert and 40,000+ other insiders.